Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2306283
rs2306283
0.030 GeneticVariation BEFREE The present study found that the allele frequencies of SLCO1B1 388A>G and 521T>C in Chinese patients with essential hyperlipidemia are comparable to those in healthy Chinese population. 20140004

2010

dbSNP: rs2306283
rs2306283
0.030 GeneticVariation BEFREE Our conclusion suggests that the interaction between the SLCO1B1 388A>G and 521T>C polymorphisms could be an important genetic determinant of hepatic function and the therapeutic efficiency of simvastatin in Chinese patients with hyperlipidemia. 30336686

2018

dbSNP: rs2306283
rs2306283
0.030 GeneticVariation BEFREE The SLCO1B1 521T > C and 388A > G variants were found to be relatively common in Chinese patients with essential hyperlipidemia. 23263738

2013

dbSNP: rs4149056
rs4149056
0.030 GeneticVariation BEFREE The SLCO1B1 521T > C and 388A > G variants were found to be relatively common in Chinese patients with essential hyperlipidemia. 23263738

2013

dbSNP: rs4149056
rs4149056
0.030 GeneticVariation BEFREE The present study found that the allele frequencies of SLCO1B1 388A>G and 521T>C in Chinese patients with essential hyperlipidemia are comparable to those in healthy Chinese population. 20140004

2010

dbSNP: rs4149056
rs4149056
0.030 GeneticVariation BEFREE Our conclusion suggests that the interaction between the SLCO1B1 388A>G and 521T>C polymorphisms could be an important genetic determinant of hepatic function and the therapeutic efficiency of simvastatin in Chinese patients with hyperlipidemia. 30336686

2018

dbSNP: rs1800206
rs1800206
0.020 GeneticVariation BEFREE The aim of this study was to investigate the individual or combined effects of PPARA-L162V, PPARG-C161T and APOE polymorphisms on hyperlipidemia in coronary heart disease (CHD) patients. 23583468

2013

dbSNP: rs1800206
rs1800206
0.020 GeneticVariation BEFREE This study examined the effect a polymorphism (L162V) in the gene for peroxisome proliferator activated receptor (PPAR) alpha in the development of non-insulin-dependent diabetes mellitus (type 2 DM), obesity and hyperlipidaemia. 11409711

2001

dbSNP: rs4994
rs4994
0.020 GeneticVariation BEFREE In conclusion, no major difference was associated with the beta3AR Trp64Arg or FABP2 Ala54Thr polymorphism in terms of type 2 diabetes or hyperlipidemia in young to older Japanese men. 11699048

2001

dbSNP: rs4994
rs4994
0.020 GeneticVariation BEFREE To determine whether this SNP affects insulin resistance syndrome associated with type 2 diabetes, we examined its effects on susceptibility to obesity, hyperlipidemia and hypertension in type 2 diabetic subjects and on susceptibility to type 2 diabetes by interaction with other frequent genes involved in lipid metabolism, namely, beta3-adrenergic receptor (b3AR) Trp64Arg, phosphodiesterase 3B (PDE3B) c.1389G>A or lysosomal acid lipase (LAL) Thr-6Pro. 12965109

2003

dbSNP: rs1042034
rs1042034
0.010 GeneticVariation BEFREE The A allele of rs1042034 and the G allele of rs676210 may thus predispose middle-aged and elderly members of the Chinese Yugur population to HL in combination with other genetic or nutritional factors, and could be used as new genetic markers for HL screening. 28902930

2017

dbSNP: rs10455872
rs10455872
LPA
0.010 GeneticVariation BEFREE Topics enriched for CVD and hyperlipidemia had positive correlations with rs10455872 (P < 0.001), replicating a previous finding. 30759150

2019

dbSNP: rs1048943
rs1048943
0.010 GeneticVariation BEFREE Hyperlipidemia could modulate the effect of CYP1A1 rs1048943 on the periodontal status of GAgP. 31032950

2019

dbSNP: rs10748835
rs10748835
0.010 GeneticVariation BEFREE The current study was to determine if coronary heart disease, hypertension, and hyperlipidemia were associated with low-level arsenic exposure and AS3MT gene single nucleotide polymorphism (SNP) A35991G (rs10748835) in rural Texas. 22341486

2012

dbSNP: rs11066280
rs11066280
0.010 GeneticVariation BEFREE Three gene variants, rs12229654, rs17249754, and rs11066280, were significantly associated with metabolic disorders such as hyperlipidemia and diabetes (P = 0.00071 to 0.0097, respectively). 24142389

2014

dbSNP: rs1137101
rs1137101
0.010 GeneticVariation BEFREE Effects of LEP G2548A and LEPR Q223R Polymorphisms on Serum Lipids and Response to Simvastatin Treatment in Chinese Patients With Primary Hyperlipidemia. 26984935

2017

dbSNP: rs11542041
rs11542041
0.010 GeneticVariation BEFREE This explains the significant effect of the apoE gene locus on the variability of plasma lipoprotein concentrations and moreover the implication of apoE alleles in the aetiology of multifactorial forms of hyperlipidaemia e.g. familial type III hyperlipidaemia (apoE2; arg158----cys) and polygenic hypercholesterolaemia (apoE4; cys112----arg). 3141688

1988

dbSNP: rs11575937
rs11575937
0.010 GeneticVariation BEFREE Heterozygosity for LMNA R482Q mutation causes FPLD, which is associated with increased risk of hyperlipidemia and hypertension. 23313286

2013

dbSNP: rs11615
rs11615
0.010 GeneticVariation BEFREE Multiplicative interactions among SNP rs11615, alcohol drinking, history of T2DM, and history of hyperlipidemia could increase 5.06-fold risk of CAD (P = 1.59 × 10<sup>-9</sup>). 28743890

2017

dbSNP: rs1217691063
rs1217691063
0.010 GeneticVariation BEFREE MTHFR C677T genetic variant contributes to simvastatin's effects among Chinese subjects with primary hyperlipidemia. 23865383

2013

dbSNP: rs121918392
rs121918392
0.010 GeneticVariation BEFREE A case of hyperlipidemia with homozygous apolipoprotein E5 (Glu3-->Lys). 12069856

2002

dbSNP: rs121964971
rs121964971
CBS
0.010 GeneticVariation BEFREE Furthermore, we characterized monocyte heterogeneity in Tg-hCBS apoE(-/-) Cbs(-/-) mice and another severe HHcy mouse model (Tg-S466L Cbs(-/-)) with a disease-relevant mutation (Tg-S466L) that lacks hyperlipidemia. 19858416

2009

dbSNP: rs12229654
rs12229654
0.010 GeneticVariation BEFREE Three gene variants, rs12229654, rs17249754, and rs11066280, were significantly associated with metabolic disorders such as hyperlipidemia and diabetes (P = 0.00071 to 0.0097, respectively). 24142389

2014

dbSNP: rs1251035592
rs1251035592
0.010 GeneticVariation BEFREE The SLCO1B1 521T > C and 388A > G variants were found to be relatively common in Chinese patients with essential hyperlipidemia. 23263738

2013

dbSNP: rs1256046734
rs1256046734
0.010 GeneticVariation BEFREE LEPR Q223R polymorphism, but not LEP G2548A, could modulate the efficacy of simvastatin in Chinese patients with primary hyperlipidemia. 26984935

2017